Kimberly-Clark (NYSE:KMB) PT Raised to $152.00

Kimberly-Clark (NYSE:KMB) had its price objective increased by research analysts at The Goldman Sachs Group from $135.00 to $152.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. The Goldman Sachs Group’s target price would suggest a potential upside of 11.41% from the company’s current price.

Other research analysts also recently issued research reports about the company. Piper Sandler boosted their price target on Kimberly-Clark from $145.00 to $152.00 and gave the company an “overweight” rating in a report on Thursday, March 28th. Wells Fargo & Company boosted their price target on Kimberly-Clark from $131.00 to $136.00 and gave the company an “equal weight” rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft boosted their price target on Kimberly-Clark from $127.00 to $132.00 and gave the company a “hold” rating in a report on Thursday, March 28th. JPMorgan Chase & Co. boosted their price target on Kimberly-Clark from $115.00 to $123.00 and gave the company an “underweight” rating in a report on Wednesday. Finally, Barclays boosted their price target on Kimberly-Clark from $124.00 to $132.00 and gave the company an “equal weight” rating in a report on Friday, April 12th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $135.50.

Kimberly-Clark Trading Down 1.0 %

NYSE KMB opened at $136.43 on Wednesday. Kimberly-Clark has a 1-year low of $116.32 and a 1-year high of $147.09. The company has a current ratio of 0.81, a quick ratio of 0.54 and a debt-to-equity ratio of 6.05. The stock has a 50-day moving average of $125.53 and a 200-day moving average of $122.75. The firm has a market cap of $45.94 billion, a PE ratio of 25.08, a price-to-earnings-growth ratio of 4.05 and a beta of 0.40.

Kimberly-Clark (NYSE:KMB) last released its earnings results on Tuesday, April 23rd. The company reported $2.01 earnings per share for the quarter, beating analysts’ consensus estimates of $1.61 by $0.40. Kimberly-Clark had a return on equity of 250.28% and a net margin of 9.05%. The company had revenue of $5.15 billion during the quarter, compared to analyst estimates of $5.08 billion. During the same quarter in the previous year, the company posted $1.67 EPS. Kimberly-Clark’s revenue for the quarter was down .9% on a year-over-year basis. As a group, sell-side analysts forecast that Kimberly-Clark will post 6.92 EPS for the current year.

Insider Buying and Selling

In related news, insider Paula Ramos sold 10,178 shares of the company’s stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $137.17, for a total value of $1,396,116.26. Following the sale, the insider now owns 795 shares in the company, valued at approximately $109,050.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Kimberly-Clark news, Director Mark T. Smucker acquired 827 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were acquired at an average cost of $120.98 per share, with a total value of $100,050.46. Following the transaction, the director now owns 827 shares of the company’s stock, valued at approximately $100,050.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Paula Ramos sold 10,178 shares of the company’s stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $137.17, for a total value of $1,396,116.26. Following the completion of the transaction, the insider now directly owns 795 shares in the company, valued at $109,050.15. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Kimberly-Clark

Several hedge funds and other institutional investors have recently added to or reduced their stakes in KMB. OFI Invest Asset Management bought a new position in Kimberly-Clark in the 3rd quarter valued at approximately $25,000. Rise Advisors LLC lifted its holdings in shares of Kimberly-Clark by 926.3% during the 1st quarter. Rise Advisors LLC now owns 195 shares of the company’s stock valued at $25,000 after buying an additional 176 shares during the period. Cranbrook Wealth Management LLC lifted its holdings in shares of Kimberly-Clark by 90.9% during the 4th quarter. Cranbrook Wealth Management LLC now owns 210 shares of the company’s stock valued at $26,000 after buying an additional 100 shares during the period. Accordant Advisory Group Inc bought a new position in shares of Kimberly-Clark during the 1st quarter valued at $27,000. Finally, Centerpoint Advisors LLC lifted its holdings in shares of Kimberly-Clark by 175.0% during the 3rd quarter. Centerpoint Advisors LLC now owns 275 shares of the company’s stock valued at $33,000 after buying an additional 175 shares during the period. 76.29% of the stock is owned by institutional investors.

About Kimberly-Clark

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.